ALYATEC evaluates pharmaceutical treatments in development or already on the market, as well as medical devices and alternative solutions such as air purifiers, dermo-cosmetics, dietary supplements or respiratory protection masks. All clinical studies executed by ALYATEC are in compliance with Good Clinical Practice (GCP).
We offer all services related to clinical studies:
- Design of clinical study protocols according to your objectives related to allergic asthma, rhinitis and conjunctivitis.
- Investigational site within multicentric clinical studies dealing with asthma, rhinoconjunctivitis, atopic dermatitis, food allergy and rhinosinusitis.
- Phase 1 to 4 clinical studies in children and adults: proof of concept, pivotal studies, post-market, onset and mechanism of action, dose-escalation.
- Real-world studies (RWE/RWD).
- Submission to health regulatory authorities and ethical committees
- Patients’ enrollment thanks to our large database of patients
- Conduction of monocentric clinical trials including ALYATEC allergen exposure chamber or natural conditions (in-field) or both (hybrid studies) including up to 200 patients
- Biological samples collection for specific biomarkers analyses
- Clinical data management and statistics
- Clinical report writing
- Writing and submission of scientific publications
- Allergen dosing
- Scientific and medical consulting
Feel free to contact us in order to set up a tailor-made clinical project that perfectly meets your development requirements.
